 Connection
Rishi Nageshan to Humans
This is a "connection" page, showing publications Rishi Nageshan has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.016 |
|
|
|
-
Singh M, Beri D, Nageshan RK, Chavaan L, Gadara D, Poojary M, Subramaniam S, Tatu U. A secreted Heat shock protein 90 of Trichomonas vaginalis. PLoS Negl Trop Dis. 2018 05; 12(5):e0006493.
Score: 0.004
-
Green JL, Moon RW, Whalley D, Bowyer PW, Wallace C, Rochani A, Nageshan RK, Howell SA, Grainger M, Jones HM, Ansell KH, Chapman TM, Taylor DL, Osborne SA, Baker DA, Tatu U, Holder AA. Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development. Antimicrob Agents Chemother. 2015 Dec 28; 60(3):1464-75.
Score: 0.003
-
Chatterjee S, Alampalli SV, Nageshan RK, Chettiar ST, Joshi S, Tatu US. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 2015 Sep 07; 16:686.
Score: 0.003
-
Roy N, Nageshan RK, Ranade S, Tatu U. Heat shock protein 90 from neglected protozoan parasites. Biochim Biophys Acta. 2012 Mar; 1823(3):707-11.
Score: 0.003
-
Pallavi R, Roy N, Nageshan RK, Talukdar P, Pavithra SR, Reddy R, Venketesh S, Kumar R, Gupta AK, Singh RK, Yadav SC, Tatu U. Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug. J Biol Chem. 2010 Dec 03; 285(49):37964-75.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|